This latter exerts a tumor suppressive function by inhibiting proliferation and malignancy of glioblastoma cells by targeting both NRAS and KRAS [60,61] and by modulating microglia activation through TLR7 [62]. This evidence concerns the gene KRAS and neoplasm.